Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01320527 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
A Phase 2 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
NCT01320527 is a Phase 2 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 135 participants.
The verdict
NCT01320527, a Phase 2 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
Study Summary
Based on prior published pilot studies, the investigators have initiated a larger, multi-site placebo-controlled clinical trial with Alzheimer's disease (AD) patients and individuals diagnosed with Mild Cognitive Impairment (MCI), with the hopes of (1) confirming (or denying) the above promising clinical findings, and (2) determining whether or not our formulation can delay MCI "conversion" to AD.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Nutriceutical formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01320527
The ClinicalTrials.gov registry entry for NCT01320527 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01320527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01320527 about?
NCT01320527 is a clinical study titled "A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease". Based on prior published pilot studies, the investigators have initiated a larger, multi-site placebo-controlled clinical trial with Alzheimer's disease (AD) patients and individuals diagnosed with Mild Cognitive Impairment (MCI), with the hopes of (1) confirming (or denying) the above promising cli...
What is the current status of trial NCT01320527?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2008-08. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01320527?
The interventions under investigation include: Placebo (OTHER), Nutriceutical formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01320527?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.